Showing results (341-350 of 3,203) with videos related to
Sort By:
Pageof 321
Journal of Chemotherapy (Florence, Italy)|April 1, 1990
Enhanced in-vitro activity of liposome-trapped penicillin-G against Pseudomonas aeruginosaH Kotsifaki, L S Tzouvelekis, G Panagiotidou, et al.Journal of Chemotherapy (Florence, Italy)|July 12, 2011
Maesopsin 4-O-beta-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemiaN Pozzesi, S Pierangeli, Carmine Vacca, et al.Journal of Chemotherapy (Florence, Italy)|July 12, 2011
Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclinesL Livi, I Meattini, V Scotti, et al.Journal of Chemotherapy (Florence, Italy)|May 2, 2012
Effect of nikkomycin Z and 50% human serum on the killing activity of high-concentration caspofungin against Candida species using time-kill methodologyJudit Szilágyi, Richárd Földi, Sedigh Bayegan, et al.Journal of Chemotherapy (Florence, Italy)|May 2, 2012
Penetration of prulifloxacin into sinus mucosa of patients undergoing paranasal sinus elective endoscopic surgeryMichele De Benedetto, Desiderio Passali, Giovanni Tomacelli, et al.Journal of Chemotherapy (Florence, Italy)|May 2, 2012
Simplification to monotherapy with lopinavir/ritonavir in adolescents with vertically acquired HIV-1 infectionEva Schenone, Antonio Di Biagio, Andrea Parisini, et al.Journal of Chemotherapy (Florence, Italy)|May 2, 2012
Antimicrobial susceptibility among E. faecalis and E. faecium from France, Germany, Italy, Spain and the UK (T.E.S.T. Surveillance Study, 2004-2009)Javier Aznar, Jose A Lepe, Michael J DowzickyJournal of Chemotherapy (Florence, Italy)|January 12, 2012
Echinocandins: are they all the same?P K Mukherjee, D Sheehan, L Puzniak, et al.Journal of Chemotherapy (Florence, Italy)|January 12, 2012
Thalidomide: an old drug with new actionV Kumar, S ChhibberJournal of Chemotherapy (Florence, Italy)|January 12, 2012
Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumptionJ Skrlin, V Bacic Vrca, S Marusic, et al.Pageof 321